Who owns the NOSCA9 trademark?

The NOSCA9 trademark is owned by Dong-A Pharmaceutical Co., Ltd..

What class is the NOSCA9 trademark registered in?

The NOSCA9 trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations).

What is the serial number for NOSCA9?

The USPTO serial number for NOSCA9 is 98095073.

What is the registration number for NOSCA9?

NOSCA9 is registered under USPTO registration number 7725342.

Sealvo

Home Search: NOSCA9NOSCA9 #98095073

Back

Updated Sep 20, 2026·31 searches this week

View on USPTO TSDR Find similar marks

NOS

USPTO Trademark Record

REGISTERED

NOSCA9

SN 98095073·Reg 7725342·Filed Jul 20, 2023

Owner Dong-A Pharmaceutical Co., Ltd.

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

NOSCA9 (Serial No. 98095073), Registration No. 7725342, is a registered US trademark filed on Jul 20, 2023 by Dong-A Pharmaceutical Co., Ltd.. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations).

early section 8: March 11, 2031

Conflict Analysis

Full conflict analysis for NOSCA9 (SN 98095073) against the USPTO database with detailed risk factor explanations. AI-powered — takes ~1-2 min.

Mark Intelligence

NOSCA9 (Reg. #7725342) is a registered US trademark that has been protecting its owner, Dong-A Pharmaceutical Co., Ltd., since 2023. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations). Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

Jul 20, 2023

SERIAL

98095073

REG#

7725342

REGISTERED

Mar 11, 2025

Filing Information

StatusREGISTERED

Filing DateJul 20, 2023

Serial Number98095073

Registration No.7725342

Registration DateMar 11, 2025

Status DateMar 11, 2025

Published for OppositionJun 18, 2024

Filing Basis & Declarations

Standard Characters ClaimedUse Application CurrentlyTrademark

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

First use anywhere: Oct 23, 2023

First use in commerce: Oct 23, 2023

This description is as filed with the USPTO and defines the scope of trademark protection.

Run a conflict check

Search by serial number, mark name, or logo. See conflicting marks ranked by risk with clear explanations of what contributed.

Run conflict check

Status History

22 events

REGISTERED-PRINCIPAL REGISTER

Mar 11, 2025

REGISTERED-PRINCIPAL REGISTER

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Mar 11, 2025

NOTICE OF REGISTRATION CONFIRMATION EMAILED

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Feb 19, 2025

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Feb 19, 2025

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Jan 19, 2025

CASE ASSIGNED TO INTENT TO USE PARALEGAL

STATEMENT OF USE PROCESSING COMPLETE

Jan 19, 2025

STATEMENT OF USE PROCESSING COMPLETE

TEAS STATEMENT OF USE RECEIVED

Nov 05, 2024

TEAS STATEMENT OF USE RECEIVED

USE AMENDMENT FILED

Nov 05, 2024

USE AMENDMENT FILED

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Aug 13, 2024

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

PUBLISHED FOR OPPOSITION

Jun 18, 2024

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Jun 18, 2024

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

May 29, 2024

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

APPROVED FOR PUB - PRINCIPAL REGISTER

May 10, 2024

APPROVED FOR PUB - PRINCIPAL REGISTER

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Apr 27, 2024

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Apr 27, 2024

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Apr 27, 2024

TEAS/EMAIL CORRESPONDENCE ENTERED

NON-FINAL ACTION WRITTEN

Mar 28, 2024

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Mar 28, 2024

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Mar 28, 2024

NOTIFICATION OF NON-FINAL ACTION E-MAILED

ASSIGNED TO EXAMINER

Mar 25, 2024

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Aug 20, 2023

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Jul 24, 2023

NEW APPLICATION ENTERED

Other Marks by Dong-A Pharmaceutical Co., Ltd.

Additional USPTO filings from the same owner.

FAT

FATION

88496857

Dong-A Pharmaceutical Co., Ltd.

REGISTERED

BAC

BACCHUS

74624918

DONG-A PHARMACEUTICAL CO., LTD.

REGISTERED

HEP

HEPARIN RX COMPLEX

98720757

Dong-A Pharmaceutical Co., Ltd.

REGISTERED

FAT

FATION

98095015

Dong-A Pharmaceutical Co., Ltd.

REGISTERED

Other Marks by CHANGHOON LEE

Additional USPTO filings handled by the same attorney of record.

NDN

ND NEXTDISC

79418637

REGISTERED

SAN

SANGSANG STORY

98226261

98589704

JUS2

88324662

REGISTERED

NOSCA9

Run a conflict check

Other Marks by Dong-A Pharmaceutical Co., Ltd.

Other Marks by CHANGHOON LEE

Get pre-filing clearance

Search 15M+ trademarks

Resources

Company